Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fecal Microbiota Transplantation in NAFLD Treatment
Ludovico Abenavoli, Valentina Maurizi, Emanuele Rinninella, et al.
Medicina (2022) Vol. 58, Iss. 11, pp. 1559-1559
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

NAFLD/MASLD and the Gut–Liver Axis: From Pathogenesis to Treatment Options
Natalia G. Vallianou, Dimitris Kounatidis, Sotiria Psallida, et al.
Metabolites (2024) Vol. 14, Iss. 7, pp. 366-366
Open Access | Times Cited: 18
Gut-liver axis: Pathophysiological concepts and medical perspective in chronic liver diseases
Susana Rodrigues, Van der Merwe, Aleksander Krag, et al.
Seminars in Immunology (2024) Vol. 71, pp. 101859-101859
Open Access | Times Cited: 15
Fecal Microbiota Transplantation in Liver Cirrhosis
Adrian Boicean, Victoria Bîrluțiu, Cristian Ichim, et al.
Biomedicines (2023) Vol. 11, Iss. 11, pp. 2930-2930
Open Access | Times Cited: 29
Efficacy of probiotics on nonalcoholic fatty liver disease: A meta-analysis
Xiangyu Zhou, Jincheng Wang, Sufang Zhou, et al.
Medicine (2023) Vol. 102, Iss. 4, pp. e32734-e32734
Open Access | Times Cited: 25
The Many Faces of Metabolic Dysfunction-Associated Fatty Liver Disease Treatment: From the Mediterranean Diet to Fecal Microbiota Transplantation
Ludovico Abenavoli, Maria Luisa Gambardella, Giuseppe Guido Maria Scarlata, et al.
(2024)
Open Access | Times Cited: 7
Non-alcoholic fatty liver disease: Immunological mechanisms and current treatments
Lucy Petagine, Mohammed Gulrez Zariwala, Vinood B. Patel
World Journal of Gastroenterology (2023) Vol. 29, Iss. 32, pp. 4831-4850
Open Access | Times Cited: 19
Fgf21-Dubosiella axis mediates the protective effects of exercise against NAFLD development
Xiaochun Ye, Peng Sun, Shuaiwei Lao, et al.
Life Sciences (2023) Vol. 334, pp. 122231-122231
Closed Access | Times Cited: 19
Gut Microbiome in the Progression of NAFLD, NASH and Cirrhosis, and Its Connection with Biotics: A Bibliometric Study Using Dimensions Scientific Research Database
Salvatore Pezzino, Maria Sofia, Chiara Mazzone, et al.
Biology (2023) Vol. 12, Iss. 5, pp. 662-662
Open Access | Times Cited: 17
Prebiotics and Probiotics: Therapeutic Tools for Nonalcoholic Fatty Liver Disease
Alejandra Mijangos-Trejo, Natalia Nuño‐Lámbarri, Varenka J. Barbero-Becerra, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14918-14918
Open Access | Times Cited: 17
Interactions between Gut Microbiota and Natural Bioactive Polysaccharides in Metabolic Diseases: Review
Yu Pi, Miaoyu Fang, Yanpin Li, et al.
Nutrients (2024) Vol. 16, Iss. 17, pp. 2838-2838
Open Access | Times Cited: 6
The role of the microbiome in liver disease
David Schöler, Bernd Schnabl
Current Opinion in Gastroenterology (2024) Vol. 40, Iss. 3, pp. 134-142
Closed Access | Times Cited: 5
The Many Faces of Metabolic Dysfunction-Associated Fatty Liver Disease Treatment: From the Mediterranean Diet to Fecal Microbiota Transplantation
Ludovico Abenavoli, Maria Luisa Gambardella, Giuseppe Guido Maria Scarlata, et al.
Medicina (2024) Vol. 60, Iss. 4, pp. 563-563
Open Access | Times Cited: 5
The gut-liver axis: emerging mechanisms and therapeutic approaches for nonalcoholic fatty liver disease and type 2 diabetes mellitus
Monika Bhardwaj, Papiya Mitra Mazumder
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access | Times Cited: 5
Beyond Auto-Brewery: Why Dysbiosis and the Legalome Matter to Forensic and Legal Psychology
Alan Logan, Susan L. Prescott, Erica M. LaFata, et al.
Laws (2024) Vol. 13, Iss. 4, pp. 46-46
Open Access | Times Cited: 5
Fecal microbiota transplantation for treatment of non-alcoholic fatty liver disease: Mechanism, clinical evidence, and prospect
Xiaoxia Qiu, Sheng‐Li Cheng, Yan‐Hui Liu, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 8, pp. 833-842
Open Access | Times Cited: 4
Chaihuang Qingyi Huoxue granule ameliorates severe acute pancreatitis by modulating gut microbiota and repairing the intestinal mucosal barrier
Xiaobin Zhang, Xiaoqun Zeng, Wen Guo, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 15
Open Access
Sirtuins and Gut Microbiota: Dynamics in Health and a Journey from Metabolic Dysfunction to Hepatocellular Carcinoma
Mahmoud Zhra, Muhammad Affan Elahi, Aamira Tariq, et al.
Cells (2025) Vol. 14, Iss. 6, pp. 466-466
Open Access
Efficacy and safety of fecal microbiota transplantation for chronic insomnia in adults: a real world study
Haiming Fang, Tingting Yao, Wanli Li, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 12
Differences in Fecal Short-Chain Fatty Acids between Alcoholic Fatty Liver-Induced Cirrhosis and Non-alcoholic (Metabolic-Associated) Fatty Liver-Induced Cirrhosis
Xinlu Cao, O. Yu. Zolnikova, Roman Maslennikov, et al.
Metabolites (2023) Vol. 13, Iss. 7, pp. 859-859
Open Access | Times Cited: 11
Targeting the Adipose Tissue–Liver–Gut Microbiota Crosstalk to Cure MASLD
Daniela Gabbia, Sara De Martin
Biology (2023) Vol. 12, Iss. 12, pp. 1471-1471
Open Access | Times Cited: 9
Updated Insights into Probiotics and Hepatobiliary Diseases
Xiaoyu Xu, Cheng Zhang, Guo‐Yi Tang, et al.
Biomedicines (2024) Vol. 12, Iss. 3, pp. 515-515
Open Access | Times Cited: 3
A catalog of ethanol-producing microbes in humans
Babacar Mbaye, Reham Magdy Wasfy, Maryam Tidjani Alou, et al.
Future Microbiology (2024) Vol. 19, Iss. 8, pp. 697-714
Open Access | Times Cited: 3
Bile acid-gut microbiota imbalance in cholestasis and its long-term effect in mice
Xin Yang, Yuesong Xu, Jiakui Li, et al.
mSystems (2024) Vol. 9, Iss. 7
Open Access | Times Cited: 3
Phage therapy in gut microbiome
Xingyao Chen, Beatriz Garcia Mendes, Bruno Secchi Alves, et al.
Progress in molecular biology and translational science (2023), pp. 93-118
Closed Access | Times Cited: 4
Gut Microbiota in Regulating Natural Bioactive Polysaccharides on Metabolic Diseases: A Review
Yu Pi, Miaoyu Fang, Yanpin Li, et al.
(2024)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top